In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Premier Inc.

Premier Invests In Exela To Procure Shortage-Hit Generic Injectables

As hospital drug shortages continue to bite in the US, a group purchasing organization has invested in generic injectables specialist Exela Pharma Sciences to garner uninterrupted supply of 19 pharmaceutical products.

Deals Generic Drugs

Pfizer Partners With Premier To Supply Critical Injectables

Pfizer has entered into an agreement with Premier to supply five essential medications to US healthcare providers through Premier’s ProvideGx program. Both companies aim to secure supply of products specifically used by COVID patients.

Coronavirus COVID-19 Deals

Drug Shortage Legislation Gains Support As Coronavirus Threatens US Supplies

Coronavirus hysteria sweeps up languishing drug shortage legislation; prospects for new reporting and risk management planning requirements improve.

Manufacturing Quality

Azar Tapped: Stakeholders Heap Praise On Trump HHS Nominee

The administration's nominee to head HHS is being praised by medtech health-care industry lobbyists but may experience some pushback in the Senate because of his ties to Eli Lilly.

Policy Executive Changes
See All

Company Information

  • Industry
  • Services
    • Outcomes Studies
    • Services sold to health care facilities
UsernamePublicRestriction

Register